MOORE TIMOTHY L.

CIK 00016692075 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001669207

Recent Transactions

50 trades

Award
CERUS CORP$CERS
Common Stock
2025-06-03+60,000→ 205,073 total
Award
BIOLIFE SOLUTIONS INC$BLFS
Common Stock
2025-03-18+6,876→ 36,773 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2025-02-03$1.71/sh−14,746→ 250,713 total
Award
CERUS CORP$CERS
Common Stock
2024-06-05$5.00/sh+40,000→ 145,073 total
Tax Payment
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-04-22$3.47/sh−17,360→ 265,459 total
Award
BIOLIFE SOLUTIONS INC$BLFS
Common Stock
2024-03-08+11,264→ 29,897 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-01-25+96,600→ 282,819 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2024-01-25+341,515→ 341,515 total
Award
BIOLIFE SOLUTIONS INC$BLFS
Common Stock
2023-11-01+495→ 18,633 total
Award
BIOLIFE SOLUTIONS INC$BLFS
Common Stock
2023-10-01+362→ 18,138 total
Award
CERUS CORP$CERS
Common Stock
2023-06-07$5.00/sh+40,000→ 105,073 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2023-04-24+831,024→ 831,024 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-04-24+186,219→ 186,219 total
Award
BIOLIFE SOLUTIONS INC$BLFS
Common Stock
2023-01-03+10,187→ 17,776 total
Award
Instil Bio, Inc.$TIL
Employee Stock Option (right to buy)
2022-09-06+750,000→ 750,000 total
Award
BIOLIFE SOLUTIONS INC$BLFS
Common Stock
2022-09-01+7,589→ 7,589 total
Award
CERUS CORP$CERS
Common Stock
2022-06-01+20,454→ 65,073 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2022-06-01+39,866→ 39,866 total
Exercise/Conversion
CERUS CORP$CERS
Restricted Stock Unit
2021-09-05−4,296→ 0 total
Exercise/Conversion
CERUS CORP$CERS
Common Stock
2021-09-05+4,296→ 44,619 total
Award
CERUS CORP$CERS
Common Stock
2021-06-02+14,888→ 40,323 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2021-06-02+29,983→ 29,983 total
Exercise/Conversion
CERUS CORP$CERS
Common Stock
2021-06-01+13,228→ 25,435 total
Exercise/Conversion
CERUS CORP$CERS
Restricted Stock Unit
2021-06-01−13,228→ 0 total
Exercise/Conversion
CERUS CORP$CERS
Restricted Stock Unit
2020-09-05−4,296→ 4,296 total
Exercise/Conversion
CERUS CORP$CERS
Common Stock
2020-09-05+4,296→ 12,207 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2020-06-03+28,177→ 28,177 total
Award
CERUS CORP$CERS
Restricted Stock Unit
2020-06-03+13,228→ 13,228 total
Purchase
CERUS CORP$CERS
Common Stock
2020-02-11$4.75/sh+3,614→ 7,911 total
Purchase
CERUS CORP$CERS
Common Stock
2020-01-29$4.15/sh+3,614→ 7,911 total
Purchase
CERUS CORP$CERS
Common Stock
2020-01-29+0→ 4,297 total
Exercise/Conversion
CERUS CORP$CERS
Restricted Stock Unit
2019-09-05−4,297→ 8,592 total
Exercise/Conversion
CERUS CORP$CERS
Common Stock
2019-09-05+4,297→ 4,297 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2019-06-05+23,703→ 23,703 total
Award
CERUS CORP$CERS
Restricted Stock Unit
2019-06-05+11,184→ 11,184 total
Award
CERUS CORP$CERS
Restricted Stock Units
2018-09-05+12,889→ 12,889 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2018-09-05+24,324→ 24,324 total
Disposition from Tender
Kite Pharma, Inc.
Common Stock
2017-10-03$180.00/sh−3,927→ 41,734 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03$135.09/sh−124,125→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Common Stock
2017-10-03−41,734→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−30,700→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−96,875→ 0 total
Sale
Kite Pharma, Inc.
Common Stock
2017-09-25$179.66/sh−4,228→ 45,661 total
Award
Kite Pharma, Inc.
Common Stock
2017-09-25+8,000→ 49,889 total
Exercise/Conversion
Kite Pharma, Inc.
Common Stock
2017-08-03$44.91/sh+6,000→ 55,400 total
Sale
Kite Pharma, Inc.
Common Stock
2017-08-03$110.10/sh−869→ 54,531 total
Sale
Kite Pharma, Inc.
Common Stock
2017-08-03$110.05/sh−5,131→ 49,400 total
Exercise/Conversion
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-08-03−6,000→ 146,000 total
Sale
Kite Pharma, Inc.
Common Stock
2017-08-01$107.58/sh−5,431→ 53,492 total
Exercise/Conversion
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-08-01−3,000→ 152,000 total

MOORE TIMOTHY L.

Recent Transactions

Companies

Recent Filings

Address